文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

经皮穿刺置管与股-股体外心肺复苏严重神经并发症发生率较低相关:来自体外生命支持组织登记研究的结果

Percutaneous cannulation is associated with lower rate of severe neurological complication in femoro-femoral ECPR: results from the Extracorporeal Life Support Organization Registry.
PubMed 文献 · Ann Intensive Care · 2023-08-30
一句话结论在成人股-股体外心肺复苏中,经皮穿刺置管与较低的严重神经并发症发生率独立相关(OR 0.62),院内死亡率、肢体缺血和置管部位出血率与外科置管相似。

该研究基于国际体外生命支持组织登记数据,纳入2008年1月至2019年12月接受股-股体外心肺复苏的成人难治性心脏骤停患者3575例,其中2749例(77%)经皮穿刺置管。研究期间经皮穿刺置管比例从18%升至89%(趋势p<0.001)。经皮组严重神经并发症发生率低于外科组(13% vs 19%;p<0.001);校正分析显示经皮穿刺置管与较低的严重神经并发症发生率独立相关(OR 0.62;95%CI 0.46-0.83;p=0.002),院内死亡率(OR 0.93;95%CI 0.73-1.17;p=0.522)、肢体缺血(OR 0.84;95%CI 0.58-1.20;p=0.341)和置管部位出血(OR 0.90;95%CI 0.66-1.22;p=0.471)率相似。不同中心经皮穿刺经验或中心ECPR量水平下结果相似。

要点

  • 成人股-股体外心肺复苏中,经皮穿刺置管与较低的严重神经并发症发生率独立相关(OR 0.62;95%CI 0.46-0.83;p=0.002)。
  • 经皮组严重神经并发症发生率为13%,外科组为19%(p<0.001)。
  • 经皮穿刺置管与院内死亡率(OR 0.93;95%CI 0.73-1.17;p=0.522)、肢体缺血(OR 0.84;95%CI 0.58-1.20;p=0.341)和置管部位出血(OR 0.90;95%CI 0.66-1.22;p=0.471)率相似。
  • 研究期间经皮穿刺置管比例从18%升至89%(趋势p<0.001)。
  • 不同中心经皮穿刺经验或中心ECPR量水平下, outcomes比较结果相似。

适用人群与场景

  • 2008年1月至2019年12月期间,国际体外生命支持组织登记中接受股-股体外心肺复苏的成人难治性心脏骤停患者。

研究设计与关键结果

  • 研究类型为基于国际体外生命支持组织登记的分析;纳入3575例接受股-股体外心肺复苏的成人难治性心脏骤停患者,其中2749例(77%)经皮穿刺置管,其余为外科置管。
  • 研究期间经皮穿刺置管比例从18%升至89%(趋势p<0.001)。
  • 主要终点严重神经并发症发生率经皮组13% vs 外科组19%(p<0.001)。
  • 校正分析:经皮穿刺置管与较低的严重神经并发症发生率独立相关(OR 0.62;95%CI 0.46-0.83;p=0.002)。
  • 校正分析:院内死亡率经皮组与外科组相似(OR 0.93;95%CI 0.73-1.17;p=0.522)。
  • 校正分析:肢体缺血率经皮组与外科组相似(OR 0.84;95%CI 0.58-1.20;p=0.341)。
  • 校正分析:置管部位出血率经皮组与外科组相似(OR 0.90;95%CI 0.66-1.22;p=0.471)。
  • 不同中心经皮穿刺经验或中心ECPR量水平下,结局比较结果相似。

证据类型、等级与局限

  • 证据类型:基于国际多中心登记数据库的分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在成人股-股体外心肺复苏中,经皮穿刺置管与较低的严重神经并发症发生率相关,且院内死亡率、肢体缺血和置管部位出血率与外科置管相似;作者结论为经皮穿刺置管可能与较低的严重神经并发症发生率相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Percutaneous cannulation is now accepted as the first-line strategy for extracorporeal cardiopulmonary resuscitation (ECPR) in adults. However, previous studies comparing percutaneous cannulation to surgical cannulation have been limited by small sample size and single-center settings. This study aimed to compare in-hospital outcomes in cardiac arrest (CA) patients who received femoro-femoral ECPR with percutaneous vs surgical cannulation.

METHODS: Adults with refractory CA treated with percutaneous (percutaneous group) or surgical (surgical group) femoro-femoral ECPR between January 2008 and December 2019 were extracted from the international Extracorporeal Life Support Organization registry. The primary outcome was severe neurological complication. Multivariable logistic regression analyses were performed to assess the association between percutaneous cannulation and in-hospital outcomes.

RESULTS: Among 3575 patients meeting study inclusion, 2749 (77%) underwent percutaneous cannulation. The proportion of patients undergoing percutaneous cannulation increased from 18% to 89% over the study period (p < 0.001 for trend). Severe neurological complication (13% vs 19%; p < 0.001) occurred less frequently in the percutaneous group compared to the surgical group. In adjusted analyses, percutaneous cannulation was independently associated with lower rate of severe neurological complication (odds ratio [OR] 0.62; 95% CI 0.46-0.83; p = 0.002), similar rates of in-hospital mortality (OR 0.93; 95% CI 0.73-1.17; p = 0.522), limb ischemia (OR 0.84; 95% CI 0.58-1.20; p = 0.341) and cannulation site bleeding (OR 0.90; 95% CI 0.66-1.22; p = 0.471). The comparison of outcomes provided similar results across different levels of center percutaneous experience or center ECPR volume.

CONCLUSIONS: Among adults receiving ECPR, percutaneous cannulation was associated with probable lower rate of severe neurological complication, and similar rates of in-hospital mortality, limb ischemia and cannulation site bleeding.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Wang L, Li C, Hao X, et al. Percutaneous cannulation is associated with lower rate of severe neurological complication in femoro-femoral ECPR: results from the Extracorporeal Life Support Organization Registry. Ann Intensive Care. 2023. PMID: 37646841. doi:10.1186/s13613-023-01174-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。